EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Deeksheetha Prabhuvenkatesh, Pratibha Ramani, Monal B Yuwanati, Gheena Sukumaran

Oncology · 2024

DOI: 10.1159/000541004 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Oncology, 2024. Verfasst von Deeksheetha Prabhuvenkatesh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, SIMATS, Chennai, India. Hauptthemen laut MEDLINE: Insulin Receptor Substrate Proteins, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Head and neck squamous cell carcinoma (HNSCC) is the most common mucosal neoplasm that affects the head and neck region. It is the 6th most common cancer globally, most commonly seen in South Asian countries. Insulin receptor substrate 1 (IRS-1), like insulin receptor, is an adapter protein that integrates multiple transmembrane signals from growth factors and hormones, to regulate cell growth, survival, differentiation, and metabolism. Evidence suggests that IRS-1 plays a vital role in cancer progression and nodal metastasis. The aim was to assess the prognostic implications of the IRS-1 expression in HNSCC from evidence-based results.

Methods

A systematic literature search was done to identify articles describing IRS-1 and HNSCC carried out for PubMed, Cochrane, and Google Scholar, using MeSH terms.

Results

A total of 486 cases of HNSCC were included in this systematic review. Out of 3 studies, increased/high expression of IRS-1 was 67%. 64% of the cases in stage I and stage II (TNM staging) showed higher expression of IRS-1, whereas 70% of stage III and stage IV cases showed upregulation of IRS-1. IRS-1 was equally upregulated in cases with lymph node metastasis as well as in cases without any lymph node metastasis. 74% of the patients who showed high expression of IRS-1 showed high mortality during the follow-up period of 13 months.

Conclusion

This review concluded that elevated levels of IRS-1 expression were associated with poor prognosis and increased lymph node metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin Receptor Substrate ProteinsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsBiomarkers, TumorCarcinoma, Squamous CellHumansPrognosisLymphatic MetastasisNeoplasm Staging

Stichwörter der Autor:innen

Head and neck squamous cell carcinomaInsulin receptor substrate 1Lymph node metastasisPrognosis

Substanzen

Insulin Receptor Substrate ProteinsIRS1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Pathology, Saveetha Dental College and Hospitals, SIMATS, Chennai, India.

Zitieren

APA

Prabhuvenkatesh, D., Ramani, P., Yuwanati, M. B., & Sukumaran, G. (2024). Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Oncology. https://doi.org/10.1159/000541004

Vancouver

Prabhuvenkatesh D, Ramani P, Yuwanati MB, Sukumaran G. Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Oncology. 2024. doi:10.1159/000541004

BibTeX
@article{Prabhuvenkatesh2024,
  author = {Prabhuvenkatesh, Deeksheetha and Ramani, Pratibha and Yuwanati, Monal B and Sukumaran, Gheena},
  title = {Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000541004}
}
Kostenlos starten →